๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Thalidomide in Cancer Treatment

โœ Scribed by Shufeng Zhou, Philip Kestell, Malcolm D. Tingle, James W. Paxton


Book ID
120807086
Publisher
Springer International Publishing AG
Year
2002
Tongue
English
Weight
230 KB
Volume
19
Category
Article
ISSN
1170-229X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Thalidomide in cancer
โœ S Singhal; J Mehta ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 101 KB
Thalidomide in cancer reviewed
๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› Adis International Limited (now part of Wolters Kl โš– 138 KB
Thalidomide effective in cancer
๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Adis International Limited (now part of Wolters Kl โš– 232 KB
THALIDOMIDE IN CANCER CHEMOTHERAPY
โœ Bach, A.; Bichel, J.; Hejgaard, J.J. ๐Ÿ“‚ Article ๐Ÿ“… 1963 ๐Ÿ› The Lancet ๐ŸŒ English โš– 158 KB
Thalidomide treatment in multiple myelom
โœ Kathrin Strasser; Heinz Ludwig ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 139 KB

Thalidomide was first evaluated in patients with refractory multiple myeloma in the mid-90s. Based on the promising results achieved in these patients, the drug was subsequently used in earlier stages of the disease. Meanwhile, numerous phase II studies have been published using different doses and